Position in JNJ
as of Jun 30, 2026
· filed Jul 15, 2026
Position Value
$44,421,892
+$1,807,934 QoQ
Shares Held
174,910
+0.3% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
1.07%
of 13F equity value
Holder Rank
#469
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Prospera Financial Services Inc holds $193,149,306 across 14 Drug Manufacturers - General names. JNJ ranks #2 (23.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
46,944 | $56,306,046 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
174,910 | $44,421,892 | |
| 3 | ABBV |
AbbVie Inc.
|
96,118 | $24,187,133 | |
| 4 | NVO |
Novo Nordisk A S
|
308,903 | $14,808,809 | |
| 5 | MRK |
Merck & Co., Inc.
|
102,060 | $13,114,710 | |
| 6 | AZN |
Astrazeneca PLC
|
56,268 | $10,669,538 | |
| 7 | AMGN |
Amgen Inc
|
26,804 | $9,706,264 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
71,841 | $9,076,391 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $44,421,892 | 174,910 | Shares | Sole | 2026-07-15 | |
| 2026-03-31 | $42,613,958 | 174,333 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $19,015,393 | 91,884 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $16,764,193 | 90,412 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $13,616,440 | 89,142 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $15,131,573 | 91,242 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $12,563,717 | 86,874 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $17,869,545 | 110,265 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $13,715,215 | 93,837 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $14,916,842 | 94,297 | Shares | Sole | 2024-08-13 | |
| 2023-12-31 | $14,132,775 | 90,167 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,579,913 | 93,611 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $15,384,090 | 92,944 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $12,132,315 | 78,273 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $9,666,994 | 54,724 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $11,038,398 | 67,571 | Shares | Sole | 2022-10-27 | |
| 2022-06-30 | $11,283,955 | 63,568 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $11,011,299 | 62,130 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $11,146,407 | 65,157 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $8,438,375 | 52,250 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,712,110 | 52,884 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $8,802,257 | 53,558 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $7,654,963 | 48,640 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,955 | 40 | Shares | Sole | 2020-11-04 | |
| 2020-06-30 | $6,011,229 | 42,745 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $5,462,613 | 41,658 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||